\begin{tabular}{p{6cm}p{1.5cm}p{2cm}p{2cm}}
& \textbf{Relative \newline Risk} & \multicolumn{2}{c}{\textbf{Contribution to Mortality}} \\[-1.5ex]
& & \emph{India} & \emph{England} \\[2ex]
%Male & 1.99 & \num{$$india_male_risk$$} & \num{$$uk_male_risk$$} \\[0.25ex]
Diabetes (Controlled) & 1.50 & \num{$$india_diabetes_contr_risk$$} & \num{$$uk_diabetes_contr_risk$$} \\[0.25ex]
Diabetes (Uncontrolled) & 2.36 & \num{$$india_diabetes_uncontr_risk$$} & \num{$$uk_diabetes_uncontr_risk$$} \\[0.25ex]
Hypertension & 0.95 & \num{$$india_bp_high_risk$$} & \num{$$uk_bp_high_risk$$} \\[0.25ex]
Obese (class I \& II) & 1.35 & \num{$$india_obese_1_2_risk$$} & \num{$$uk_obese_1_2_risk$$} \\[0.25ex]
Obese (class III) & 2.27 & \num{$$india_obese_3_risk$$} & \num{$$uk_obese_3_risk$$} \\[0.25ex]
Chronic Heart Disease & 1.27 & \num{$$india_chronic_heart_dz_risk$$} & \num{$$uk_chronic_heart_dz_risk$$} \\[0.25ex]
Chronic Respiratory Disease & 1.78 & \num{$$india_chronic_resp_dz_risk$$} & \num{$$uk_chronic_resp_dz_risk$$} \\[0.25ex]
Asthma & 1.25 & \num{$$india_asthma_ocs_risk$$} & \num{$$uk_asthma_ocs_risk$$} \\[0.25ex]
Kidney Disease & 1.72 & \num{$$india_kidney_dz_risk$$} & \num{$$uk_kidney_dz_risk$$} \\[0.25ex]
Chronic Liver Disease & 1.61 & \num{$$india_liver_dz_risk$$} & \num{$$uk_liver_dz_risk$$} \\[0.25ex]
Haematological Cancer & 3.52 & \num{$$india_haem_malig_1_risk$$} & \num{$$uk_haem_malig_1_risk$$} \\[0.25ex]
Non-haematological Cancer & 1.56 & \num{$$india_cancer_non_haem_1_risk$$} & \num{$$uk_cancer_non_haem_1_risk$$} \\[0.25ex]
Stroke, Dementia & 1.79 & \num{$$india_stroke_dementia_risk$$} & \num{$$uk_stroke_dementia_risk$$} \\[0.25ex]
Other Neurological Condition & 2.46 & \num{$$india_neuro_other_risk$$} & \num{$$uk_neuro_other_risk$$} \\[0.25ex]
Psoriasis, Rheumatoid & 1.23 & \num{$$india_autoimmune_dz_risk$$} & \num{$$uk_autoimmune_dz_risk$$} \\[0.25ex]
Other Immunosuppressive Conditions & 1.69 & \num{$$india_immuno_other_dz_risk$$} & \num{$$uk_immuno_other_dz_risk$$} \\[0.25ex]
\end{tabular}

